Circuit Event and Unfilled Demand
The stock of Venus Remedies Ltd reached its maximum allowed daily gain of 5%, closing at Rs 909.55 after opening at Rs 883.05. This price band capped the upside, effectively freezing trading at the ceiling price. The total traded volume was 0.30841 lakh shares, with a turnover of approximately Rs 2.79 crore. The upper circuit indicates that demand exceeded what the price band could accommodate, leaving unfilled buy orders on the books. This phenomenon is typical for stocks hitting circuit limits, especially in segments where liquidity is not abundant. Venus Remedies Ltd’s session exemplifies this dynamic, where the exchange ceiling stopped the rally, not the buyers — what does the full demand picture look like for Venus Remedies once the circuit unlocks and normal trading resumes?
Delivery and Volume Analysis
Delivery volume, a key indicator of genuine buying interest, fell by 18.15% compared to the 5-day average, with 22,470 shares delivered on 24 Mar 2026. This decline suggests that while the stock hit the upper circuit, the buying was not strongly backed by long-term accumulation on this particular day. Volume on a circuit day is mechanically suppressed due to the price lock, but the falling delivery volume points to a more speculative or short-term interest rather than conviction buying. The total traded volume was also lower than usual, consistent with the circuit mechanism limiting liquidity. is Venus Remedies' upper circuit move driven by conviction or thin liquidity? — the delivery data provides a nuanced view of the session’s quality.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Moving Averages and Trend Context
Venus Remedies Ltd is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day lines. This alignment confirms a bullish trend that preceded the circuit event, with the upper circuit amplifying an already positive momentum. The stock is also trading close to its 52-week high, just 4.57% shy of Rs 944.75, signalling strength in the price action. The intraday range was relatively narrow, with a low of Rs 883.05 and a high at the circuit price of Rs 909.55, reflecting the price band’s limiting effect. does the moving average configuration support sustained momentum beyond the circuit day?
Liquidity and Market Capitalisation Context
With a market capitalisation of approximately Rs 1,209 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is modest, with the stock liquid enough for a trade size of around Rs 0.08 crore based on 2% of the 5-day average traded value. This limited liquidity means that while the upper circuit is a notable event, the ability to enter or exit sizeable positions without impacting the price is constrained. For micro-cap stocks, such liquidity risk is as important as the momentum signal — should investors factor in liquidity constraints when assessing Venus Remedies' recent surge?
Intraday Price Action
The stock opened with a gap up of 2.51%, setting a positive tone for the session. The price steadily climbed to the upper circuit limit, touching Rs 909.55 before trading was halted at that ceiling. The narrow intraday range near the circuit price is typical for such moves, where the price band restricts further upside and compresses volatility. This pattern indicates that the buying pressure was persistent throughout the day but capped mechanically by the exchange rules.
Fundamental Snapshot
Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the stock’s recent price action is primarily technical, the company’s fundamentals provide a backdrop of a micro-cap with potential in a specialised industry. The stock has outperformed its sector by 2.43% on the day, reflecting relative strength within its peer group.
Want to dive deeper on Venus Remedies Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Conclusion: Circuit, Delivery, and Liquidity Signals
The upper circuit hit by Venus Remedies Ltd on 25 Mar 2026 reflects strong buying interest capped by exchange-imposed price limits. However, the falling delivery volume tempers the conviction narrative, suggesting some speculative elements in the rally. The stock’s position above all key moving averages confirms an underlying bullish trend, but the micro-cap status and limited liquidity introduce a cautionary note. The circuit locked in gains but also locked out buyers who arrived late — after a 4.3% single-day gain at upper circuit, is Venus Remedies still worth considering or has the move already happened?
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
